|
Right lobe living donor liver transplantation is an effective treatment for selected individuals with end-stage liver disease.
Although 1 year donor morbidity and mortality have been reported, little is known about outcomes beyond 1 year.
Dr Adcock and colleagues from Canada analyzed the outcomes of the first 202 consecutive donors performed with a minimum follow-up of 12 months.
All physical complications were prospectively recorded and categorized according to the modified Clavien classification system.
 | | Donor survival was 100% | | American Journal of Transplantation |
The researchers identified donors by a dedicated family physician at 2 weeks, 1, 3 and 12 months postoperatively and yearly thereafter.
The cohort included 108 males and 94 females.
The research team found that donor survival was 100%.
A total of 40% of donors experienced a medical complication during the first year after surgery.
After 1 year, 3 donors experienced a medical complication.
All donors returned to predonation employment or studies although 2% of donors experienced a psychiatric complication.
Dr Adcock's team concluded, “This prospective study suggests that living liver donation can be performed safely without any serious late medical complications.”
“This study suggests that long-term follow-up may contribute to favorable donor outcomes.”
| 
Email this page to a colleague
